12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Entero Therapeutics (NASDAQ:ENTO) stock rose 10.2% to $2.6 during Monday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Pulmonx (NASDAQ:LUNG) shares rose 29.5% to $10.0 during Wednesday’s after-market session. The market value of their outstanding…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares increased by 11.0% to $0.73 during Friday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Processa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday’s pre-market session. The company’s market…
Compass Therapeutics Receives FDA Fast Track Designation For The Investigation Of CTX-009 In Combination With Paclitaxel For The Treatment Of Patients With Metastatic Or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated
CTX-009, the Company's bispecific DLL4/VEGF-A antibody, in combination with paclitaxel, has shown promising clinical responses in patients with advanced biliary tract cancer (BTC) in its Phase 2 studyTop-line data
Compass Therapeutics Presents Data Demonstrating Elimination Of MHC Class I Negative Tumors In Models At 2024 AACR Annual Meeting
Major Histocompatibility Complex Class I (MHC-I) negative tumors are refractory to immune-oncology therapies, including resistance to checkpoint blockers, due to the loss of the fundamental recognition of the tumor by
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Talphera (NASDAQ:TLPH) stock moved upwards by 10.5% to $0.85 during Wednesday’s after-market session. The company’s market cap…
Compass Therapeutics Provides Corporate Update
We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC). Consistent with
Recap: Compass Therapeutics Q3 Earnings
Compass Therapeutics (NASDAQ:CMPX) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:30 AM. Here’s what…
Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Gainers
Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday.